36 Results

People

  1. Landgren
    Landgren
  2. Korde
    Korde
  3. Mailankody
    Mailankody
  4. Lesokhin
    Lesokhin
  5. Rustad
    Rustad
  6. Yellapantula
    Yellapantula
  7. Hassoun
    Hassoun
  8. Papaemmanuil
    Papaemmanuil
  9. Chung
    Chung
  10. Giralt
    Giralt

Groups

  1. Center for Hematologic Malignancies (36)
  2. Department of Medicine (36)
  3. Hematologic Malignancies Research (36)
  4. Hematologic Malignancies, Division of (36)
  5. Myeloma (36)
  6. Survivorship Research (10)
  7. Epidemiology and Biostatistics (9)
  8. Sloan Kettering Institute Postdocs (9)
  9. GSK Faculty (7)
  10. Tow Center for Developmental Oncology (TCDO) (7)
  1. "article"
  2. "Hematologic Malignancies Research"
  3. "Carl Landgren"
Formats
  1. Journal Article (33)
  2. Research Letter (2)
  3. Review (1)
Groups
  1. Center for Hematologic Malignancies (36)
  2. Department of Medicine (36)
  3. Hematologic Malignancies Research (36)
  4. Hematologic Malignancies, Division of (36)
  5. Myeloma (36)
  6. Survivorship Research (10)

More Groups

People
  1. Carl Landgren (36)
  2. Neha Korde (9)
  3. Sham Mailankody (8)
  4. Alexander Lesokhin (7)
  5. Even Rustad (7)
  6. Venkata Yellapantula (7)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (4)
  4. 2020 (11)
  5. 2019 (4)
  6. 2018 (4)

More Years

Publications
  1. Haematologica (3)
  2. Leukemia (3)
  3. American Journal of Hematology (2)
  4. Journal of Molecular Diagnostics (2)
  5. Leukemia and Lymphoma (2)
  6. Nature Communications (2)

More Publications

Publishers
  1. Nature Publishing Group (7)
  2. Elsevier Inc. (4)
  3. Elsevier Science, Inc. (3)
  4. Ferrata Storti Foundation (3)
  5. John Wiley & Sons (3)
  6. Springer (3)

More Publishers

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: A case for response-adapted approach
    Journal Article

    Lahoud, O. B.; Landau, H.; Nguyen, J.; Devlin, S.; Lendvai, N.; Weltz, J.; Ayorinde, T.; Chung, D. J.; Lesokhin, A. M.; Kewalramani, T.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Pesticide use and kidney function among farmers in the Biomarkers of Exposure and Effect in Agriculture study
    Journal Article

    Shearer, J. J.; Sandler, D. P.; Andreotti, G.; Murata, K.; Shrestha, S.; Parks, C. G.; Liu, D.; Alavanja, M. C.; Landgren, O.; Beane Freeman, L. E.; more...
    Environmental Research (2021)

    Fulltext@MSK | Save
  • Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
    Research Letter

    Lee, H. C.; Raje, N. S.; Landgren, O.; Upreti, V. V.; Wang, J.; Avilion, A. A.; Hu, X.; Rasmussen, E.; Ngarmchamnanrith, G.; Fujii, H.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
    Journal Article

    Alsina, M.; Landgren, O.; Raje, N.; Niesvizky, R.; Bensinger, W. I.; Berdeja, J. G.; Kovacsovics, T.; Vesole, D. H.; Fang, B.; Kimball, A. S.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • A population-based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival
    Journal Article

    Steingrímsson, V.; Gíslason, G. K.; Aspelund, T.; Turesson, I.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
    European Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
    Journal Article

    Rowinsky, E. K.; Paner, A.; Berdeja, J. G.; Paba-Prada, C.; Venugopal, P.; Porkka, K.; Gullbo, J.; Linder, S.; Loskog, A.; Richardson, P. G.; more...
    Investigational New Drugs (2020)

    Fulltext@MSK | Save
  • Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: A randomized, open-label, multicenter, phase 2 study (CENTAURUS)
    Journal Article

    Landgren, C. O.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P.; Estell, J. A.; Sandhu, I.; Jenner, M. W.; Williams, C.; Cavo, M.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Accelerated single cell seeding in relapsed multiple myeloma
    Journal Article

    Landau, H. J.; Yellapantula, V.; Diamond, B. T.; Rustad, E. H.; Maclachlan, K. H.; Gundem, G.; Medina-Martinez, J.; Arango Ossa, J.; Levine, M. F.; Zhou, Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save